{
  "legislationId": "119_HR_8032",
  "lastUpdate": "2026-04-13T14:28:44.512Z",
  "history": [
    {
      "timestamp": "2026-04-13T14:28:44.512Z",
      "source_url": "https://www.congress.gov/119/bills/hr8032/BILLS-119hr8032ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8032 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8032 To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, cancer treatments under the Medicare hospital outpatient prospective payment system. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 20, 2026 Mr. Dunn of Florida (for himself and Mr. Soto) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, cancer treatments under the Medicare hospital outpatient prospective payment system. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Facilitating Access to Innovation in Cancer Care Act'' or the ``FAIC Act''. SEC. 2. SEPARATE PAYMENT FOR CERTAIN CANCER TREATMENTS. Section 1833(t)(16) of the Social Security Act (42 U.S.C. 1395(t)(16)) is amended by adding at the end the following new subparagraph: ``(H) Separate payment for certain cancer treatments.-- ``(i) In general.--Notwithstanding any other provision of this subsection, with respect to a specified cancer treatment (as defined in clause (v)) furnished during a year (beginning with 2026), the Secretary shall not package payment for such treatment into a payment for a covered OPD service (or group of services), and shall make a separate payment as specified in clause (ii) for such treatment, if such treatment has an estimated mean per day product cost equal to or exceeding the threshold specified in clause (iii) for such year. ``(ii) Separate payment.--For purposes of clause (i), the separate payment specified in this clause for a specified cancer treatment is a payment in an amount equal to-- ``(I) the average sales price for such treatment established under section 1847A, as calculated and adjusted by the Secretary to the extent such adjustment is adopted for other specified covered outpatient drugs under paragraph (14)(A)(iii)(II); or ``(II) if the data necessary to calculate such average sales price for such treatment is not available, the wholesale acquisition cost (as defined in subsection 1847A(c)(6)(B)) for such treatment, as calculated and adjusted by the Secretary to the extent such adjustment is adopted for other specified covered outpatient drugs under paragraph (14)(A), or, if such wholesale acquisition cost is not available, the mean unit cost for such treatment (as derived from hospital claims data). ``(iii) Threshold.--For purposes of clause (i), the threshold specified in this clause is-- ``(I) for 2026, $350; and ``(II) for a subsequent year, the amount specified in this clause for the preceding year, increased by the OPD fee schedule increase factor under paragraph (3)(C)(iv) for the year. ``(iv) Budget neutrality.--The Secretary shall make such adjustments as are necessary under this subsection to ensure that the amount of expenditures under this subsection for a year with application of this subparagraph is equal to the amount of expenditures that would be made under this subsection for such year without application of this subparagraph. ``(v) Definition.--For purposes of this subparagraph, the term `specified cancer treatment' means a drug or biological that-- ``(I) is approved by the Food and Drug Administration on or after January 1, 2008, for use in the detection or treatment of cancer; ``(II) does not receive transitional pass-through payments under paragraph (6); and ``(III) has payment that would, but for application of this subparagraph, be packaged into a payment for a covered OPD service (or group of services).''. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Facilitating Access to Innovation in Cancer Care Act (FAIC Act)\nSummary: This bill changes how Medicare pays hospitals for expensive cancer drugs to ensure patients can access the latest treatments. By paying for these drugs separately rather than as part of a bundle, it encourages hospitals to offer innovative therapies.\nKey Points: Requires separate Medicare payments for high-cost cancer treatments instead of bundling them into a single flat fee., Improves patient access to innovative drugs and biologicals approved by the FDA since 2008., Ensures hospitals are fairly reimbursed for providing advanced and expensive cancer care., Sets a cost threshold ($350 per day in 2026) for treatments to qualify for separate payment.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": true,\n  \"issue\": \"none\"\n}"
    },
    {
      "timestamp": "2026-04-13T14:04:18.573Z",
      "source_url": "https://www.congress.gov/119/bills/hr8032/BILLS-119hr8032ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8032 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8032 To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, cancer treatments under the Medicare hospital outpatient prospective payment system. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 20, 2026 Mr. Dunn of Florida (for himself and Mr. Soto) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, cancer treatments under the Medicare hospital outpatient prospective payment system. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Facilitating Access to Innovation in Cancer Care Act'' or the ``FAIC Act''. SEC. 2. SEPARATE PAYMENT FOR CERTAIN CANCER TREATMENTS. Section 1833(t)(16) of the Social Security Act (42 U.S.C. 1395(t)(16)) is amended by adding at the end the following new subparagraph: ``(H) Separate payment for certain cancer treatments.-- ``(i) In general.--Notwithstanding any other provision of this subsection, with respect to a specified cancer treatment (as defined in clause (v)) furnished during a year (beginning with 2026), the Secretary shall not package payment for such treatment into a payment for a covered OPD service (or group of services), and shall make a separate payment as specified in clause (ii) for such treatment, if such treatment has an estimated mean per day product cost equal to or exceeding the threshold specified in clause (iii) for such year. ``(ii) Separate payment.--For purposes of clause (i), the separate payment specified in this clause for a specified cancer treatment is a payment in an amount equal to-- ``(I) the average sales price for such treatment established under section 1847A, as calculated and adjusted by the Secretary to the extent such adjustment is adopted for other specified covered outpatient drugs under paragraph (14)(A)(iii)(II); or ``(II) if the data necessary to calculate such average sales price for such treatment is not available, the wholesale acquisition cost (as defined in subsection 1847A(c)(6)(B)) for such treatment, as calculated and adjusted by the Secretary to the extent such adjustment is adopted for other specified covered outpatient drugs under paragraph (14)(A), or, if such wholesale acquisition cost is not available, the mean unit cost for such treatment (as derived from hospital claims data). ``(iii) Threshold.--For purposes of clause (i), the threshold specified in this clause is-- ``(I) for 2026, $350; and ``(II) for a subsequent year, the amount specified in this clause for the preceding year, increased by the OPD fee schedule increase factor under paragraph (3)(C)(iv) for the year. ``(iv) Budget neutrality.--The Secretary shall make such adjustments as are necessary under this subsection to ensure that the amount of expenditures under this subsection for a year with application of this subparagraph is equal to the amount of expenditures that would be made under this subsection for such year without application of this subparagraph. ``(v) Definition.--For purposes of this subparagraph, the term `specified cancer treatment' means a drug or biological that-- ``(I) is approved by the Food and Drug Administration on or after January 1, 2008, for use in the detection or treatment of cancer; ``(II) does not receive transitional pass-through payments under paragraph (6); and ``(III) has payment that would, but for application of this subparagraph, be packaged into a payment for a covered OPD service (or group of services).''. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa o ułatwieniu dostępu do nowoczesnego leczenia nowotworów (FAIC Act)\",\n  \"pl_summary\": \"Ustawa zmienia sposób, w jaki Medicare płaci szpitalom za nowoczesne leki przeciwnowotworowe, co ma ułatwić pacjentom dostęp do najnowszych terapii. Zamiast wliczać koszt drogich leków w ogólną opłatę za wizytę, szpitale otrzymają za nie oddzielny zwrot kosztów.\",\n  \"pl_key_points\": [\n    \"Wprowadzenie oddzielnych płatności za drogie leki onkologiczne zamiast łączenia ich w jedną niską opłatę ryczałtową.\",\n    \"Lepszy dostęp dla pacjentów do innowacyjnych terapii zatwierdzonych przez FDA po 2008 roku.\",\n    \"Zapewnienie szpitalom uczciwego zwrotu kosztów za stosowanie zaawansowanych i kosztownych metod leczenia raka.\",\n    \"Ustalenie progu kosztowego (350 USD dziennie w 2026 r.), powyżej którego leki będą opłacane osobno.\"\n  ],\n  \"eng_ai_title\": \"Facilitating Access to Innovation in Cancer Care Act (FAIC Act)\",\n  \"eng_summary\": \"This bill changes how Medicare pays hospitals for expensive cancer drugs to ensure patients can access the latest treatments. By paying for these drugs separately rather than as part of a bundle, it encourages hospitals to offer innovative therapies.\",\n  \"eng_key_points\": [\n    \"Requires separate Medicare payments for high-cost cancer treatments instead of bundling them into a single flat fee.\",\n    \"Improves patient access to innovative drugs and biologicals approved by the FDA since 2008.\",\n    \"Ensures hospitals are fairly reimbursed for providing advanced and expensive cancer care.\",\n    \"Sets a cost threshold ($350 per day in 2026) for treatments to qualify for separate payment.\"\n  ],\n  \"de_ai_title\": \"Gesetz zur Erleichterung des Zugangs zu innovativer Krebsbehandlung (FAIC Act)\",\n  \"de_summary\": \"Dieses Gesetz ändert die Art und Weise, wie Medicare Krankenhäuser für teure Krebsmedikamente bezahlt, um den Zugang der Patienten zu modernsten Therapien zu sichern. Krankenhäuser erhalten nun separate Zahlungen für diese Medikamente, anstatt sie in einer Pauschale abrechnen zu müssen.\",\n  \"de_key_points\": [\n    \"Einführung separater Medicare-Zahlungen für teure Krebsbehandlungen anstelle von Pauschalbeträgen.\",\n    \"Verbesserter Zugang für Patienten zu innovativen Medikamenten, die seit 2008 zugelassen wurden.\",\n    \"Sicherstellung einer fairen Erstattung für Krankenhäuser, die fortschrittliche Krebstherapien anbieten.\",\n    \"Festlegung einer Kostenschwelle von 350 USD pro Tag für das Jahr 2026 für die separate Vergütung.\"\n  ],\n  \"fr_ai_title\": \"Loi visant à faciliter l'accès aux innovations en cancérologie (FAIC Act)\",\n  \"fr_summary\": \"Ce projet de loi modifie le mode de remboursement par Medicare des médicaments anticancéreux coûteux afin de garantir l'accès des patients aux traitements les plus récents. Les hôpitaux recevront un paiement distinct pour ces médicaments au lieu d'un forfait global.\",\n  \"fr_key_points\": [\n    \"Mise en place de paiements séparés pour les traitements contre le cancer à coût élevé au lieu d'un tarif groupé.\",\n    \"Amélioration de l'accès des patients aux médicaments innovants approuvés par la FDA depuis 2008.\",\n    \"Garantie d'un remboursement équitable pour les hôpitaux fournissant des soins oncologiques de pointe.\",\n    \"Fixation d'un seuil de coût de 350 $ par jour en 2026 pour bénéficier du paiement séparé.\"\n  ],\n  \"es_ai_title\": \"Ley para facilitar el acceso a la innovación en el tratamiento del cáncer (FAIC Act)\",\n  \"es_summary\": \"Esta ley cambia la forma en que Medicare paga a los hospitales por los medicamentos costosos contra el cáncer para asegurar que los pacientes tengan acceso a los últimos tratamientos. Al pagar estos fármacos por separado, se evita que los hospitales pierdan dinero al ofrecer terapias avanzadas.\",\n  \"es_key_points\": [\n    \"Establece pagos separados de Medicare para tratamientos oncológicos de alto costo en lugar de incluirlos en un pago único.\",\n    \"Mejora el acceso de los pacientes a medicamentos innovadores aprobados por la FDA a partir de 2008.\",\n    \"Asegura un reembolso justo para los hospitales que brindan cuidados oncológicos avanzados y costosos.\",\n    \"Define un umbral de costo de 350 dólares diarios en 2026 para calificar para el pago por separado.\"\n  ],\n  \"it_ai_title\": \"Legge per facilitare l'accesso all'innovazione nelle cure oncologiche (FAIC Act)\",\n  \"it_summary\": \"Questa legge modifica il modo in cui Medicare rimborsa gli ospedali per i farmaci oncologici costosi, garantendo ai pazienti l'accesso alle terapie più recenti. Invece di un pagamento forfettario, gli ospedali riceveranno rimborsi separati per questi trattamenti specifici.\",\n  \"it_key_points\": [\n    \"Prevede pagamenti separati per trattamenti oncologici ad alto costo invece di accorparli in un'unica tariffa.\",\n    \"Migliora l'accesso dei pazienti ai farmaci innovativi approvati dalla FDA dopo il 2008.\",\n    \"Garantisce un rimborso equo agli ospedali che offrono cure oncologiche avanzate e costose.\",\n    \"Stabilisce una soglia di costo di 350 dollari al giorno nel 2026 per l'accesso al pagamento separato.\"\n  ],\n  \"nl_ai_title\": \"Wet ter bevordering van toegang tot innovatieve kankerzorg (FAIC Act)\",\n  \"nl_summary\": \"Deze wet wijzigt de manier waarop Medicare ziekenhuizen betaalt voor dure kankermedicijnen om de toegang van patiënten tot de nieuwste behandelingen te waarborgen. Door deze medicijnen apart te vergoeden in plaats van als onderdeel van een pakket, worden ziekenhuizen gestimuleerd om innovatieve therapieën aan te bieden.\",\n  \"nl_key_points\": [\n    \"Verplicht aparte Medicare-betalingen voor dure kankerbehandelingen in plaats van een gecombineerd vast bedrag.\",\n    \"Verbetert de toegang voor patiënten tot innovatieve medicijnen die sinds 2008 door de FDA zijn goedgekeurd.\",\n    \"Zorgt voor een eerlijke vergoeding voor ziekenhuizen die geavanceerde en dure kankerzorg verlenen.\",\n    \"Stelt een kostendrempel vast van 350 dollar per dag in 2026 voor aparte vergoeding.\"\n  ],\n  \"pt_ai_title\": \"Lei para facilitar o acesso à inovação no tratamento do cancro (FAIC Act)\",\n  \"pt_summary\": \"Esta lei altera a forma como o Medicare paga aos hospitais pelos medicamentos oncológicos caros, garantindo que os pacientes tenham acesso aos tratamentos mais recentes. Ao pagar estes fármacos separadamente, evita-se que os hospitais tenham prejuízos ao oferecer terapias inovadoras.\",\n  \"pt_key_points\": [\n    \"Exige pagamentos separados do Medicare para tratamentos oncológicos de alto custo em vez de um pagamento fixo agrupado.\",\n    \"Melhora o acesso dos pacientes a medicamentos inovadores aprovados pela FDA desde 2008.\",\n    \"Garante um reembolso justo para os hospitais que prestam cuidados oncológicos avançados e dispendiosos.\",\n    \"Define um limite de custo de 350 dólares por dia em 2026 para qualificar para o pagamento separado.\"\n  ],\n  \"category\": [\"Health\"]\n}"
    }
  ]
}